What’s new? What was emphatic before is wishy-washy now. The last time the US Preventive Services Task Force weighed in on prostate cancer screening via blood tests, in 2012, it issued unambiguous advice to physicians: discourage men of all ages from getting tested for levels of prostate-specific antigen (PSA). That’s still the advice for men...
Category: <span>Cancer</span>
Post
Developing adoptive T-cell therapy for ovarian cancer
Preclinical research on T-cell therapy is described in a new report, showing how engineered T cells can kill both human and mouse ovarian cancer cells in the lab and significantly extend survival in a mouse model. Fred Hutchinson Cancer Research Center immunotherapy researchers Drs. Kristin Anderson and Philip Greenberg and their colleagues are working on...
Post
Combo Rx plus stem-cell tx ups PFS in multiple myeloma
Combination therapy with lenalidomide, bortezomib, and dexamethasone (RVD) plus stem-cell transplantation is associated with longer progression-free survival than RVD alone for adults with multiple myeloma, according to a study published in the April 6 issue of the New England Journal of Medicine. The Study: Michel Attal, M.D., from the Institut Universitaire du Cancer de Toulouse-Oncopole...
Post
Team examines use of antiparasitic drug as new treatment for brain tumors
Marc Symons, PhD, professor at the Feinstein Institute for Medical Research is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. Marc Symons, PhD, professor in The Feinstein Institute for Medical Research’s Karches Center for Oncology Research, is examining if a common medication administered...
Post
Researchers find novel way to induce pancreatic cancer cell death
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients. In an effort to better...
Post
Should you get screened for prostate cancer? We break down the latest advice
A panel of experts in preventive medicine released a draft proposal Tuesday on screening for prostate cancer. “Another one?” you may ask, remembering an earlier recommendation. Don’t worry; we’re here to help you avoid whiplash: What’s new? What was emphatic before is wishy-washy now. The last time the US Preventive Services Task Force weighed in on prostate cancer...
Post
Developing adoptive T-cell therapy for ovarian cancer
Fred Hutchinson Cancer Research Center immunotherapy researchers Drs. Kristin Anderson and Philip Greenberg and their colleagues are working on ways to tweak their team’s early successes with T-cell therapy for leukemia to apply to solid tumors. In a presentation on April 4 at the annual meeting of the American Association of Cancer Research in Washington,...
Post
Combo Rx plus stem-cell tx ups PFS in multiple myeloma
Michel Attal, M.D., from the Institut Universitaire du Cancer de Toulouse-Oncopole in France, and colleagues randomized patients with multiple myeloma to receive induction therapy with three cycles of RVD, then consolidation therapy with either five additional cycles of RVD (350 patients) or high-dose melphalan plus stem-cell transplantation followed by two additional RVD cycles (350 patients). The researchers found that...
Post
“Sci-fi” cancer therapy fights brain tumors, study finds
In this March 29, 2017 photo, Joyce Endresen wears an Optune therapy device for brain cancer, as she speaks on a phone at work in Aurora, Ill. She was diagnosed in December 2014 with Glioblastoma. WASHINGTON — Although it sounds like science fiction, a cap-like device that makes electric fields to fight cancer improved survival for the first...
Post
Artificial thymus can produce cancer-fighting T cells from blood stem cells
T cells (red) that were produced using artificial thymic organoids developed by UCLA scientists. UCLA researchers have created a new system to produce human T cells, the white blood cells that fight against disease-causing intruders in the body. The system could be utilized to engineer T cells to find and attack cancer cells, which...